It was previously demonstrated that sustained activation (30 -60 min) of protein kinase C (PKC) results in translocation of PKC ␣ and II to the pericentrion, a dynamic subset of the recycling compartment whose formation is dependent on PKC and phospholipase D (PLD). Here we investigated whether the formation of the pericentrion modulates the ability of PKC to phosphorylate substrates, especially if it reduces substrate phosphorylation by sequestering PKC. Surprisingly, using an antibody that detects phosphosubstrates of classical PKCs, the results showed that the majority of PKC phosphosubstrates are phosphorylated with delayed kinetics, correlating with the time frame of PKC translocation to the pericentrion. Substrate phosphorylation was blocked by PLD inhibitors and was not observed in response to activation of a PKC II mutant (F663D) that is defective in interaction with PLD and in internalization. Phosphorylation was also inhibited by blocking clathrin-dependent endocytosis, demonstrating a requirement for endocytosis for the PKC-dependent major phosphorylation effects. Serotonin receptor activation by serotonin showed a similar response to phorbol 12-myristate 13-acetate, implicating a potential role of delayed kinetics in G protein-coupled receptor signaling. Evaluation of candidate substrates revealed that the phosphorylation of the PKC substrate p70S6K kinase behaved in a similar manner. Gradient-based fractionation revealed that the majority of these PKC substrates reside within the pericentrion-enriched fractions and not in the plasma membrane. Finally, proteomic analysis of the pericentrion-enriched fractions revealed several proteins as known PKC substrates and/or proteins involved in endocytic trafficking. These results reveal an important role for PKC internalization and for the pericentrion as key determinants/amplifiers of PKC action.Protein kinase C (PKC) isoenzymes constitute a family of serine threonine kinases involved in cell signaling in response to the generation of lipid second messengers. PKC isoenzymes are divided into three families (classical, novel, and atypical) that have in common a regulatory amino-terminal domain and a carboxyl-terminal kinase domain containing motifs required for catalysis (1-3). The three major PKC isoforms (␣,  (I and II), and ␥) constitute the classical PKC (cPKC) 2 class and are activated by diacylglycerol (DAG) and calcium, which bind the C1 and C2 domain, respectively, in the amino terminus. Novel PKC (nPKC) isoforms (, ␦, ⑀, and ) are calcium-independent isoforms because of a truncated non-functional C2 domain, whereas the atypical PKCs ( and /) are both calcium-and DAG-independent because of a truncation in both their C1 and C2 domains (1, 4). In the carboxyl terminus, the C3 domain is a typical ATP-binding domain, whereas the C4 domain contains a substrate-binding site (2). The plant-derived tumor promoter, phorbol 12-myristate 13-acetate (PMA), functions as a direct and potent activator of cPKCs and nPKCs (5).According to current understanding, PKC...